National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

autologous heat-shock protein 70 peptide vaccine AG-858
A recombinant cancer vaccine made with tumor-derived heat shock protein 70 (HSP70) peptide complexes. HSP70 associates with antigenic peptides, transporting them into antigen presenting cells (APC) for processing. Tumor-derived HSP70-peptide complexes used in vaccine preparations have been shown to prime tumor immunity and tumor-specific T cells in animal models. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Code name:AG-858



Previous:autologous EBV-CTL CD19CAR zeta, autologous EBV-transformed B lymphoblastoid-tumor fusion cell vaccine, autologous Epstein-Barr virus-specific cytotoxic T lymphocytes, autologous Epstein-Barr virus-transformed B-lymphoblastoid cell vaccine, autologous expanded mesenchymal stem cells OTI-010
Next:autologous immunoglobulin idiotype-KLH conjugate vaccine, autologous LMP1-/LMP2- specific cytotoxic T-lymphocytes, autologous OFA-iLRP RNA-transfected dendritic cell vaccine, autologous PBTL CD19CAR-28 zeta, autologous tumor cell vaccine

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov